1-4 of 4
Kevin Camphausen
Close
Sort by
Journal Articles

A Phase II Pilot Study of Avelumab in Combination with Hypofractionated Radiotherapy in Patients with Relapsed Refractory Multiple Myeloma

Emily Bryer, DO, Alexander Dew, DO, MS, Elizabeth Hill, MD, Elizabeth Gil Ramirez, MD, Candis Morrison, CNP, PhD, Ashley Carpenter, RN, Monica Epstein, RN, Michael Emanuel, BSN, RN, Kevin Camphausen, MD, Jennifer Jones, MD PhD, Dickran Kazandjian, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–11.
https://doi.org/10.1182/blood-2020-136176
Published: 2020
Journal Articles

A prospective study of mediastinal gray-zone lymphoma

Clinical Trials & Observations
Wyndham H. Wilson, Stefania Pittaluga, Alina Nicolae, Kevin Camphausen, Margaret Shovlin, Seth M. Steinberg, Mark Roschewski, Louis M. Staudt, Elaine S. Jaffe, Kieron Dunleavy
Journal: Blood
Blood (2014) 124 (10): 1563–1569.
https://doi.org/10.1182/blood-2014-03-564906
Published: 2014
Journal Articles

Keratinocyte growth factor augments immune reconstitution after autologous hematopoietic progenitor cell transplantation in rhesus macaques.

Ruth Seggewiss, Karin Loré, F. Javier Guenaga, Stefania Pittaluga, Joseph Mattapallil, Catherine K. Chow, Richard A. Koup, Kevin Camphausen, Martha C. Nason, Martin Meier-Schellersheim, Robert E. Donahue, Bruce R. Blazar, Cynthia E. Dunbar, Daniel C. Douek
Journal: Blood
Blood (2007) 110 (1): 441–449.
https://doi.org/10.1182/blood-2006-12-065623
Published: 2007
Includes: Supplemental data
Journal Articles

A Prospective Trial of Radiation Alone vs Combination Chemotherapy Alone for Early-Stage Hodgkin’s Disease: Implications of 25-Year Follow-Up to Current Combined Modality Therapy.

Dan L. Longo, Eli Glatstein, Patricia L. Duffey, Robert C. Young, Shelby Fiem, Elaine S. Jaffe, Kevin Camphausen, Wyndham Wilson, Vincent T. DeVita
Journal: Blood
Blood (2006) 108 (11): 98.
https://doi.org/10.1182/blood.V108.11.98.98
Published: 2006